Gene Sequencing Market Research Report Information By Product Type (Consumables, Instruments, and Services), By Application (Oncology, Reproductive Health, Clinical Investigation, Consumer Genomics, Metagenomics, and Others), By Workflow (Pre-Sequencing, Sequencing, and Data Analysis), By End User (Academic Research, Clinical Research, Hospitals, Pharmaceutical Companies, and Others), By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Global Gene Sequencing Market Overview

Gene Sequencing Size was valued at USD 13.6 Billion in 2022. The gene sequencing market industry is projected to grow from USD 16.59 Billion in 2023 to USD 81.428 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 22.00% during the forecast period (2024 - 2032). Growth in genome mapping programs globally, increased use of next-generation sequencing in diagnostic procedures, demand from oncology departments, and awareness of early diagnosis and detection of chronic diseases are the main market drivers propelling the market's expansion.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Gene Sequencing Market Trends

• Increasing number of infectious diseases is driving the market growth

The market CAGR is being driven by an increase in the number of infectious illness cases and a rise in the need for effective medications and vaccines. The demand for pharmaceutical and therapeutic treatments, such as vaccines, has also aided the rapid growth of the global genome sequencing market. After a comprehensive examination of the SARS-CoV-2 virus's genome (RNA), several industry players successfully created a vaccine to ward off infection due to government support. Several factors, including high costs, process reliability, and the potential for human mortality from COVID-19, have driven recent developments in genome sequencing. These factors also contributed to the growth of the worldwide genome sequencing market in the following years. For instance, the entire human genome project, which will be used to improve genome sequencing technology, received USD 4435 million from government agencies, including the National Institutes for Health in the United States.

There is expected to be a significant increase in cancer cases, which is good news for the growth of the oncology industry. As the prevalence of cancer rises, the need for effective patient classification is driving research efforts to identify biomarkers and develop companion diagnostics. Researching cancer-related illnesses in novel ways is now feasible due to gene sequencing technology advances. With targeted medications becoming the new standard of care in oncology, NGS-driven diagnostics are often considered to guide the choice of treatments to improve patient outcomes. Consequently, there will be a greater demand for NGS sequencers in cancer research institutes. The industry is expected to grow as long as clinical gene sequencing is successfully used to diagnose and treat uncommon genetic diseases.

The global market for gene sequencing is primarily driven by the proliferation of advanced technical platforms and enhanced genomic tools. Continuous improvements in quicker sequencing techniques and various methodologies to handle the massive amounts of data created are speeding up the analysts' ability to evaluate microbial networks from an infinite diversity of habitats. The increasing usability of advanced bioinformatics tools, high throughput sequencing (HTS) techniques, the recovery of new drugs, and the creation of affordable innovations such as next-generation sequencing (NGS) are driving the market's expansion. Thus, driving the gene sequencing market revenue.

Gene Sequencing Market Segment Insights

• 
  

  Gene Sequencing Product Type Insights

  
  

The Gene Sequencing segmentation, based on product type, includes Consumables, Instruments, and Services. The consumables segment dominated the market. Consumables for whole genome sequencing come in various forms, such as application kits, consumables for sequencing, sample preparation, library preparation, barcoding, and more. The expansion of this market sector may be ascribed to the accessibility of an extensive array of consumables for researching genetic characterizations, various species, and mutations linked to disease.

• 
  

  Gene Sequencing Application Insights

  
  

The Gene Sequencing segmentation, based on application, includes Oncology, Reproductive Health, Clinical Investigation, Consumer Genomics, Metagenomics, and Others. The oncology category generated the most income. The development of cancer therapies and diagnostics has the most potential for this technology. By 2022, there should be almost 2 million new cases of cancer and 600,000 cancer-related deaths, according to the National Center for Health Statistics. The demand for novel cancer treatments and diagnostics is fueled by the rising number of cancer cases, which propels the segment's expansion.

• 
  

  Gene Sequencing Workflow Insights

  
  

The Gene Sequencing segmentation, based on workflow, includes Pre-Sequencing, Sequencing, and Data Analysis. The sequencing category generated the most income. DNA-protein interactions and genome sequence profiling are made possible by this technique. It makes a greater contribution because it is an essential part of the entire workflow for gene sequencing used in research and discovery projects. Sequencers' ability to generate large amounts of data quickly improves our knowledge of how to address human health issues and illnesses.

Figure 1: Gene Sequencing, by Workflow, 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Gene Sequencing End User Insights

The Gene Sequencing segmentation, based on end user, includes Academic Research, Clinical Research, Hospitals, Pharmaceutical Companies, and Others. The academic research category generated the most income. The US, UK, Germany, France, China, and several research institutes and standalone genomic laboratories are mostly responsible for the widespread use of genome sequencing technologies. These centers carry out large-scale studies on the sequence structural levels of genomics to create personalized and effective novel treatments that improve quality of life, restore mobility, and improve surgical results for patients with various illnesses.

Gene Sequencing Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American gene sequencing market area will dominate this market. The region's expansion is credited to the government and private institutions' booming funding and assistance programs. The industry is expanding at a substantial rate thanks to the government's favorable policies and the increasing adoption of cutting-edge technologies.

Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: GENE SEQUENCING SHARE BY REGION 2023 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe gene sequencing market accounts for the second-largest market share. The region's market is expected to rise due to the existence of research and academic institutes working in genomics, a developed healthcare system, and awareness of the important uses of genome sequencing in healthcare. Further, the German gene sequencing market held the largest market share, and the UK gene sequencing market was the fastest growing market in the European region.

The Asia-Pacific Gene Sequencing Market is expected to grow at the fastest CAGR from 2024 to 2032. The government's attempts to establish a genetic database are expected to propel growth in this region due to its vast population. This database will be used in the future for precautionary and preventive medicine. Moreover, China’s gene sequencing market held the largest market share, and the Indian gene sequencing market was the fastest growing market in the Asia-Pacific region.

Gene Sequencing Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the gene sequencing market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the gene sequencing industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global gene sequencing industry to benefit clients and increase the market sector. In recent years, the gene sequencing industry has offered some of the most significant advantages to medicine. Major players in the gene sequencing market are attempting to increase market demand by investing in research and development operations, including Intrexon Bioinformatics Germany GmbH, QIAGEN, Myriad Genetics, Eurofins Scientific, PierianDx, Agilent Technologies, Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Pacific Biosciences of California, Inc., and Illumina, Inc.

Myriad Genetics Inc. (Myriad) is a specialty molecular diagnostic firm that offers clinical and pharmacological services for major diseases. It is also involved in personalized medicine and the development and commercialization of molecular diagnostic tests. The company offers a range of products, including molecular diagnostic testing, which evaluates genes, genetic expressions, and corresponding proteins to evaluate an individual's susceptibility to diseases in later life; products for disease diagnosis; and tools for predicting a patient's propensity to respond to a specific medication.

For genetic analysis, Illumina Inc. (Illumina) offers array-based solutions and gene sequencing services in the fields of cancer, translational and consumer genomics, and molecular diagnostics. The company's product line includes arrays and reagents, molecular biology reagents, microarray kits and reagents, sequencing tools and systems, and sequencing kits and reagents. It provides microarray services, instrument services, training, and consultation in addition to human whole-genome sequencing. The company provides services to clinical research organizations, genomic research institutes, pharmaceutical companies, academic institutions, and biotechnology enterprises.

Key companies in the gene sequencing market include

• Intrexon Bioinformatics Germany GmbH


• QIAGEN


• Myriad Genetics


• Eurofins Scientific


• PierianDx


• Agilent Technologies, Inc.


• Thermo Fisher Scientific


• F. Hoffmann-La Roche Ltd.


• Pacific Biosciences of California, Inc.


• Illumina, Inc.

Gene Sequencing Industry Developments

May 2022: Together, Deerfield Management and Illumina, Inc. are taking a genetically driven approach to discover new drugs and further fulfill unmet medical requirements. The partnership aims to accelerate the approval of innovative therapeutics that use genetic expertise and genomic methodologies to fuse AI and genomics.

April 2022: For the treatment of cancer patients, C2i Genomics, a company based in New York, unveiled its whole genome minimal residual illness test. With a 3 to 4 ml blood sample, this AI-powered application has the potential to reliably and swiftly diagnose cancer. The test assists in monitoring the course of the illness and determining the efficacy of treatment for personalized care.

Gene Sequencing Market Segmentation

Gene Sequencing Product Type Outlook

• Consumables


• Instruments


• Services

Gene Sequencing Application Outlook

• Oncology


• Reproductive Health


• Clinical Investigation


• Consumer Genomics


• Metagenomics


• Others

Gene Sequencing Workflow Outlook

• Pre-Sequencing


• Sequencing


• Data Analysis

Gene Sequencing End User Outlook

• Academic Research


• Clinical Research


• Hospitals


• Pharmaceutical Companies


• Others

Gene Sequencing Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  •  Japan
  
  
  •  India
  
  
  •  Australia
  
  
  •  South Korea
  
  
  • Australia
  
  
  •  Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America